Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Morjani

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Cancers|February 25, 2023
Molecular Links between Cancer and Metabolic Diseases: New Perspectives and Therapeutic Strategies for Cancer Prevention and Treatment by Targeting Nutritional Patterns and Metabolic AlterationsMohamed Zaiou, Hamid Morjani
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2009
Immunosuppressors as multidrug resistance reversal agentsHamid Morjani, Claudie Madoulet
Breast Cancer Research and Treatment|June 29, 2002
Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cellsDavid Chauvier, Hamid Morjani, Michel Manfait
International Journal of Oncology|March 15, 2002
Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cellsDavid Chauvier, Hamid Morjani, Michel Manfait
Leukemia Research|August 7, 2002
Free radical production and labile iron pool decrease triggered by subtoxic concentration of aclarubicin in human leukemia cell linesDoriane Richard, Hamid Morjani, Benoît Chénais
Journal of Neurochemistry|June 18, 2002
Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron poolBenoît Chénais, Hamid Morjani, Jean-Claude Drapier
Cancers|May 13, 2023
BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current KnowledgeLaetitia Florent, Charles Saby, Florian Slimano, et al.
Frontiers in Cell and Developmental Biology|January 10, 2022
Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell PhenotypeCharles Saby, Erik Maquoi, Frédéric Saltel, et al.
Critical Reviews in Oncology/Hematology|June 28, 2005
Immunosuppressors and reversion of multidrug-resistanceNassera Aouali, Lahcen Eddabra, Jérôme Macadré, et al.
Journal of Pharmaceutical Sciences|July 13, 2002
Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecinDavid Chauvier, Gregory Kegelaer, Hamid Morjani, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Cancers|February 25, 2023
Molecular Links between Cancer and Metabolic Diseases: New Perspectives and Therapeutic Strategies for Cancer Prevention and Treatment by Targeting Nutritional Patterns and Metabolic AlterationsMohamed Zaiou, Hamid Morjani
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2009
Immunosuppressors as multidrug resistance reversal agentsHamid Morjani, Claudie Madoulet
Breast Cancer Research and Treatment|June 29, 2002
Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cellsDavid Chauvier, Hamid Morjani, Michel Manfait
International Journal of Oncology|March 15, 2002
Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cellsDavid Chauvier, Hamid Morjani, Michel Manfait
Leukemia Research|August 7, 2002
Free radical production and labile iron pool decrease triggered by subtoxic concentration of aclarubicin in human leukemia cell linesDoriane Richard, Hamid Morjani, Benoît Chénais
Journal of Neurochemistry|June 18, 2002
Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron poolBenoît Chénais, Hamid Morjani, Jean-Claude Drapier
Cancers|May 13, 2023
BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current KnowledgeLaetitia Florent, Charles Saby, Florian Slimano, et al.
Frontiers in Cell and Developmental Biology|January 10, 2022
Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell PhenotypeCharles Saby, Erik Maquoi, Frédéric Saltel, et al.
Critical Reviews in Oncology/Hematology|June 28, 2005
Immunosuppressors and reversion of multidrug-resistanceNassera Aouali, Lahcen Eddabra, Jérôme Macadré, et al.
Journal of Pharmaceutical Sciences|July 13, 2002
Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecinDavid Chauvier, Gregory Kegelaer, Hamid Morjani, et al.
Pageof 10